Corbalis Corp. to provide further details about securities, financial and legal issues in Investor Conference Call on October 5.
Irvine, CA (PRWEB) September 28, 2010
Cobalis Corp. (Pink Sheets: CLSC.PK) is holding the second Investor Update Conference Call to provide investors and shareholders with further details and the latest updates about a range of important securities, financial and legal issues.
Shareholders and investors MUST RSVP to participate in this conference call, to be held Tuesday, October 5, 2010 at 1:15pm Pacific Time. Interested parties may RSVP to participate in the call by contacting Cobalis at (949) 260-0123 between 9:00 am and 5:00 pm Pacific Time, Monday through Friday, to get the conference call dial-in number and passcode.
The agenda of this call will include: Financial status and private funding; details of current legal and corporate issues; update on the recent SEC complaint and resolution; resumption of trading; launch update; current legal settlements and how the Company is meeting the terms of its agreements; overview of additional revenue opportunities; what happened with previously planned product release dates.
There will also be a Question and Answer opportunity as well as opportunities following the Conference Call for one-on-one discussions with interested parties.
FORWARD LOOKING STATEMENTS
Cobalis Corp., expectation of results and other forward-looking statements contained in this email involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those expected are the following: business conditions and general economic conditions; competitive factors, such as pricing and marketing efforts; and the pace and success of product research and development. These and other factors may cause expectations to differ.
ABOUT COBALIS CORP—PREHISTIN®
Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World’s FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.
For PreHistin® product information and ordering please visit at http://www.PreHistin.com or call toll free 1-877-4POLLEN. For additional company information please visit the corporate website at http://www.Cobalis.com
16795 Von Karman, Suite 200
Irvine, CA 92606
Chas Radovich, President
# # #